Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer Ltd.

Division of Pfizer Inc.

Latest From Pfizer Ltd.

'Affordable' Russian Rituximab Biosimilar On Course In India

Biocad’s biosimilar rituximab appears headed for an Indian debut amid significant competition but the Russian firm appears confident that its “full-cycle production” will give it an edge and also facilitate a flexible pricing policy.

Biosimilars Approvals

‘Excessive Pricing’ Inquiry Widens As EC’s First Antitrust Price Probe Targets Aspen Pharma

The litany of complaints against pharmaceutical companies for imposing “excessive” prices on generic drugs is growing after the European Commission decided to pursue Aspen Pharma over price rises imposed on a range of anticancer products it acquired from GSK.

Europe Generic Drugs

Record Fine For Pfizer Throws Spotlight On UK Generic Pricing

Following the decision by the UK competition authority to fine Pfizer and Flynn Pharma for “unfair and excessive” pricing, generic prices are to be brought under tighter government control. But it remains to be seen how these controls will be applied in practice where companies are suspected of excessive pricing, and exactly what might constitute an “unreasonable price,” say Gustaf Duhs and Astrid Arnold.

Legal Issues Pricing Strategies

Appointments: Merck KGaA, Myovant, Scholar Rock, C4X Discovery, Paragon Bioservices and Gamida Cell.

This week's roundup includes appointments by Merck KGaA, C4X Discovery Holdings, Paragon Bioservices and board appointments by Scholar Rock, Myovant Sciences and Gamida Cell.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Ken Moran, Chmn. & Managing Dir.
    Ian Read, Pres.
  • Contact Info
  • Pfizer Ltd.
    Phone: (44) 1301 616161
    Ramsgate Rd.
    Sandwich, CT13 9NJ